| MEREO BIOPHARMA ADR |
| USA |
| Gesundheit |
| US5894921072 / A2PEYJ |
| MAH0 (Frankfurt) / MREO (NASDAQ) |
| FRA:MAH0, ETR:MAH0, MAH0:GR, NASDAQ:MREO |
| - |
| https://www.mereobiopharm.. |
|
Mereo BioPharma Group plc is structured as an American Depositary Receipt (ADR), a financial asset that provides US investors easy access to the shares of the UK-based biopharmaceutical company on Ame..
>Volltext.. |
| 50.01 Mio. EUR |
| 9.18 Mio. EUR |
| 0.43 Mio. EUR |
| -39.24 Mio. EUR |
| -35.23 Mio. EUR |
| -0.22 EUR |
| 0.34 Mio. EUR |
| 41.16 Mio. EUR |
| -27.64 Mio. EUR |
| 8.09 |
| -94.24% |
| -33.35% |
| - |
| - |
| - |
| - |
| MEREO BIOPHARMA ADR, MEREO BIOPHARMA, MEREO BIO |
| 20.02.26 |
|